Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1439)
  3. Review (82)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3394)
  2. Solid Tumor Oncology Division (3394)
  3. GSK Faculty (1071)
  4. Department of Pathology and Laboratory Medicine (809)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (662)
  6. Human Oncology and Pathogenesis Program (635)

More Groups

People
  1. Mark Kris (872)
  2. Alexander Drilon (637)
  3. Gregory Riely (605)
  4. Charles Rudin (495)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (114)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (703)
  2. Journal of Thoracic Oncology (517)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (158)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (782)
  2. Elsevier Inc. (738)
  3. American Association for Cancer Research (386)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3394)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Primary efficacy and biomarker analyses from the VISION study of tepotinib in patients (pts) with non-small cell lung cancer (NSCLC) with METex14 skipping
    Meeting Abstract

    Le, X.; Felip, E.; Veillon, R.; Sakai, H.; Cortot, A. B.; Garassino, M. C.; Mazieres, J.; Ramirez, S. V.; Senellart, H.; Van Meerbeeck, J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • MSK-ACCESS for noninvasive somatic mutation profiling of lung cancers utilizing circulating tumor DNA
    Meeting Abstract

    Lebow, E. S.; Murciano-Goroff, Y. R.; Brannon, A. R.; Zehir, A.; Arcila, M. E.; Benayed, R.; Chaft, J. E.; Drilon, A. E.; Kris, M. G.; Gomez, D. R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Quality of life of adults and children with TRK fusion cancer treated with larotrectinib compared to the general population
    Meeting Abstract

    Kummar, S.; Van Tilburg, C. M.; Albert, C. M.; Berlin, J.; Farago, A. F.; McDermott, R. S.; Bielack, S. S.; Doz, F. P.; DuBois, S. G.; Lassen, U. N.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Molecular subtypes and clinical outcomes to initial systemic treatment in patients with small cell lung cancer
    Meeting Abstract

    Lai, W. C. V.; Egger, J. V.; Rizvi, H.; Richards, A. L.; Beras, A.; Baine, M. K.; Hsieh, M. S.; Chang, J. C.; Rekhtman, N.; Plodkowski, A. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Progression-free survival estimates in non-small cell lung cancer when RECIST is unavailable: Project GENIE's integration of genomic, therapeutic and phenomic data
    Meeting Abstract

    Lavery, J. A.; Panageas, K.; LeNoue-Newton, M.; Sweeney, S.; Sheffler-Collins, S.; Rudolph, J. E.; Rizvi, H.; Schultz, N.; Lepisto, E. M.; Kehl, K. L.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • CodeBreak 100: Phase I study of AMG 510, a novel KRAS(G12C) inhibitor, in patients (pts) with advanced solid tumors other than non-small cell lung cancer (NSCLC) and colorectal cancer (CRC)
    Meeting Abstract

    Hong, D. S.; Kuo, J.; Sacher, A. G.; Barlesi, F.; Besse, B.; Kuboki, Y.; Dy, G. K.; Dembla, V.; Krauss, J. C.; Burns, T. F.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Selpercatinib (LOXO-292) in patients with RET-fusion+ non-small cell lung cancer
    Meeting Abstract

    Goto, K.; Oxnard, G. R.; Tan, D. S. W.; Loong, H. H. F.; Bauer, T. M.; Gainor, J. F.; McCoach, C. E.; Gautschi, O.; Besse, B.; Cho, B. C.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Nivolumab (NIVO) plus ipilimumab (IPI) with two cycles of chemotherapy (chemo) in first-line metastatic non-small cell lung cancer (NSCLC): CheckMate 568 Part 2
    Meeting Abstract

    Gainor, J. F.; Schneider, J. G.; Gutierrez, M.; Orcutt, J. M.; Finley, G. G.; Otterson, G. A.; Rybkin, I. I.; Reddy, P. S.; Horn, L.; Brahmer, J. R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase I/Ib study of lenvatinib and cetuximab in patients with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Dunn, L.; Ho, A. L.; Eng, J.; Michel, L. S.; Fetten, J. V.; Warner, E.; Kriplani, A.; Zhi, W. I.; Ng, K. K.; Haque, S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • CodeBreak 100: Activity of AMG 510, a novel small molecule inhibitor of KRAS(G12C), in patients with advanced colorectal cancer
    Meeting Abstract

    Fakih, M.; Desai, J.; Kuboki, Y.; Strickler, J. H.; Price, T. J.; Durm, G. A.; Falchook, G. S.; Denlinger, C. S.; Krauss, J. C.; Shapiro, G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save